JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (31) Citing Articles via Google Scholar Google Scholar Articles by Fischer, L. G. Articles by Durieux, M. E. Search for Related Content PubMed PubMed Citation Articles by Fischer, L. G. Articles by Durieux, M. E. Related Collections Pain

---

REGIONAL ANESTHESIA AND PAIN MEDICINE

Local Anesthetics Attenuate Lysophosphatidic Acid-Induced Priming in Human Neutrophils

Lars G. Fischer, MD^§, Maria Bremer, Elizabeth J. Coleman, MS, Beate Conrad, Boris Krumm, Ariane Gross^||, Markus W. Hollmann, MD^||, Gerald Mandell, MD, and Marcel E. Durieux, MD, PhD^*

*Department of Anesthesiology, University Hospital Maastricht, The Netherlands, the Departments of Medicine (Infectious Diseases) and Anesthesiology, University of Virginia Health System, Charlottesville, Virginia, §Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Westfälische-Wilhelms-Universität, Münster, Germany, ||Department of Anesthesiology, University of Heidelberg, Heidelberg, Germany

Address correspondence and reprint requests to Marcel E. Durieux, MD, PhD, Department of Anesthesiology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands. Address e-mail to durieux{at}virginia.edu

Lysophosphatidic acid (LPA) is an intercellular phospholipid mediator with a variety of actions that suggest a role in stimulating inflammatory responses. We therefore studied its actions on neutrophil (PMN) motility and respiratory burst. Because local anesthetics (LA) inhibit LPA signaling and attenuate PMN responses, we also investigated the effects of LA on these actions. Chemotaxis of human PMNs under agarose toward LPA (10^-10–10^-3 M) was studied, with and without 1 h prior incubation in lidocaine (10^-9–10^-4 M). Priming as well as activating effects of LPA on PMNs were measured using a cytochrome-c assay of superoxide anion (O₂^-) production. PMNs were incubated with lidocaine, tetracaine, or S-(-) ropivacaine (all at 10^-6–10^-4 M) for 10 min or 1 h to assess interference with LPA signaling. LPA demonstrated chemoattractive effects towards human PMNs; this effect was concentration-dependently attenuated by lidocaine. LPA alone did not activate PMNs. However, it acted as a priming agent. LA in clinically relevant concentrations decreased O₂^- production induced by LPA/N-formylmethionine-leucyl-phenylanaline. LPA acts as a chemoattractant and priming agent; however, it does not activate PMNs. LA, in clinically relevant concentrations, attenuate chemotactic and metabolic responses as a result of LPA. These results may explain the antiinflammatory effect of local anesthestics.

Implications: Lysophosphatidic acid (LPA) influences two functions of human neutrophils, migration and metabolic activity. It acted as a chemoattractant and a priming–but not activating–agent. Responses to LPA were attenuated by local anesthetics in clinically relevant concentrations.

This article has been cited by other articles:

				S. P. Desai, K. Kojima, C. A. Vacanti, and S. Kodama Lidocaine Inhibits NIH-3T3 Cell Multiplication by Increasing the Expression of Cyclin-Dependent Kinase Inhibitor 1A (p21) Anesth. Analg., November 1, 2008; 107(5): 1592 - 1597. [Abstract] [Full Text] [PDF]

				C. Sato, A. Sakai, Y. Ikeda, H. Suzuki, and A. Sakamoto The Prolonged Analgesic Effect of Epidural Ropivacaine in a Rat Model of Neuropathic Pain Anesth. Analg., January 1, 2008; 106(1): 313 - 320. [Abstract] [Full Text] [PDF]

				M. Rahaman, R. W. Costello, K. E. Belmonte, S. S. Gendy, and M.-T. Walsh Neutrophil Sphingosine 1-Phosphate and Lysophosphatidic Acid Receptors in Pneumonia Am. J. Respir. Cell Mol. Biol., February 1, 2006; 34(2): 233 - 241. [Abstract] [Full Text] [PDF]

				A. Jinnouchi, Y. Aida, K. Nozoe, K. Maeda, and M. J. Pabst Local anesthetics inhibit priming of neutrophils by lipopolysaccharide for enhanced release of superoxide: suppression of cytochrome b558 expression by disparate mechanisms J. Leukoc. Biol., December 1, 2005; 78(6): 1356 - 1365. [Abstract] [Full Text] [PDF]

				R.-R. Ji and G. Strichartz Cell Signaling and the Genesis of Neuropathic Pain Sci. Signal., September 28, 2004; 2004(252): re14 - re14. [Abstract] [Full Text] [PDF]

				J. Vinten-Johansen Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury Cardiovasc Res, February 15, 2004; 61(3): 481 - 497. [Abstract] [Full Text] [PDF]

				M. W. Hollmann, K. Kurz, S. Herroeder, D. Struemper, K. Hahnenkamp, N. S. Berkelmans, C. G. den Bakker, and M. E. Durieux The Effects of S(-)-, R(+)-, and Racemic Bupivacaine on Lysophosphatidate-Induced Priming of Human Neutrophils Anesth. Analg., October 1, 2003; 97(4): 1053 - 1058. [Abstract] [Full Text] [PDF]

				K. Hahnenkamp, G. Theilmeier, H. K. Van Aken, and C. W. Hoenemann The Effects of Local Anesthetics on Perioperative Coagulation, Inflammation, and Microcirculation Anesth. Analg., June 1, 2002; 94(6): 1441 - 1447. [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999